Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $839.49 billion, total revenue of $166.46 billion and a weighted average PE ratio of 54.34.
Market Cap
839.49B
Revenue
166.46B
Profits
15.45B
PE Ratio
54.34
Profit Margin
9.28%
Dividend Yield
0.19%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 240.25B | 0.50% | 2,621,506 | 43.74B |
| 2 | DHR | Danaher Corporation | 169.58B | -0.81% | 2,955,050 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 55.18B | -0.78% | 453,731 | 4.17B |
| 4 | IQV | IQVIA Holdings Inc. | 40.71B | -0.97% | 1,327,126 | 15.90B |
| 5 | A | Agilent Technologies, Inc. | 39.30B | -0.82% | 1,453,170 | 6.95B |
| 6 | NTRA | Natera, Inc. | 33.60B | 0.05% | 971,272 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 29.38B | -0.33% | 91,597 | 3.94B |
| 8 | WAT | Waters Corporation | 23.84B | 0.94% | 521,256 | 3.11B |
| 9 | ILMN | Illumina, Inc. | 23.52B | 0.96% | 1,668,197 | 4.29B |
| 10 | LH | Labcorp Holdings Inc. | 22.38B | 0.31% | 735,310 | 13.77B |
| 11 | DGX | Quest Diagnostics Incorporated | 20.26B | -1.35% | 1,754,195 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.43B | -0.11% | 4,360,237 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.08B | -2.31% | 182,885 | 2.36B |
| 14 | GH | Guardant Health, Inc. | 15.11B | 1.32% | 3,002,629 | 902.57M |
| 15 | ICLR | ICON Public Limited Company | 14.26B | 1.01% | 542,618 | 8.10B |
| 16 | RVTY | Revvity, Inc. | 13.35B | 1.05% | 1,882,378 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 11.18B | -2.53% | 4,210,663 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 11.03B | -1.21% | 521,256 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 5.64B | 1.35% | 609,044 | 1.97B |
| 20 | SHC | Sotera Health Company | 5.37B | -0.42% | 1,195,200 | 1.15B |
| 21 | GRAL | GRAIL, Inc. | 4.52B | 14.83% | 1,393,817 | 141.83M |
| 22 | BLLN | BillionToOne, Inc. | 4.14B | 7.67% | 154,054 | 254.14M |
| 23 | VCYT | Veracyte, Inc. | 3.46B | 1.15% | 1,068,920 | 495.14M |
| 24 | WGS | GeneDx Holdings Corp. | 2.94B | 1.84% | 873,627 | 402.19M |
| 25 | TWST | Twist Bioscience Corporation | 2.77B | 3.44% | 1,416,957 | 376.57M |
| 26 | NEOG | Neogen Corporation | 2.16B | 0.56% | 2,719,721 | 880.32M |
| 27 | NEO | NeoGenomics, Inc. | 1.68B | 2.21% | 1,683,594 | 709.16M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.23B | 2.86% | 251,582 | 343.53M |
| 29 | CDNA | CareDx, Inc. | 1.08B | 0.91% | 657,579 | 358.00M |
| 30 | OPK | OPKO Health, Inc. | 1.04B | -1.45% | 3,018,661 | 642.07M |
| 31 | PSNL | Personalis, Inc. | 999.05M | 16.58% | 2,079,164 | 69.10M |
| 32 | FLGT | Fulgent Genetics, Inc. | 870.80M | 1.15% | 155,585 | 315.55M |
| 33 | MYGN | Myriad Genetics, Inc. | 564.88M | 3.77% | 1,342,291 | 825.30M |
| 34 | BNR | Burning Rock Biotech Limited | 442.08M | 32.20% | 111,003 | 75.75M |
| 35 | PRE | Prenetics Global Limited | 318.06M | 15.46% | 475,321 | 77.08M |
| 36 | MDXH | MDxHealth SA | 205.41M | 6.96% | 356,067 | 103.07M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 191.48M | 2.61% | 15,885 | 4.40M |
| 38 | FONR | FONAR Corporation | 121.98M | -0.37% | 85,476 | 105.43M |
| 39 | XGN | Exagen Inc. | 110.82M | 3.38% | 792,663 | 63.60M |
| 40 | BDSX | Biodesix, Inc. | 88.31M | 1.65% | 450,936 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 42.71M | -1.26% | 6,707 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 19.75M | 3.96% | 122,541 | 513.02M |
| 43 | MYNZ | Mainz Biomed N.V. | 10.69M | - | 842,706 | 659.94K |
| 44 | MBAI | Check-Cap Ltd. | 9.36M | -8.93% | 33,234 | - |
| 45 | ADVB | Advanced Biomed Inc. | 7.37M | 4.19% | 49,292 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 6.11M | 3.82% | 70,402 | 6.78M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 5.47M | 8.82% | 32,750 | - |
| 48 | ISPC | iSpecimen Inc. | 3.76M | 21.45% | 898,115 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 1.94M | -21.77% | 1,450,514 | 29.52M |